Unmet Needs and the Future of Desmoid Tumor Management

Our conference coverage featured updates on clinical trials testing new treatments for NSCLC, bladder cancer, and breast cancer.

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Studies indicate that ultrasound-based AI models significantly outperform sonographers in diagnosing ovarian cancer.

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.

Fuzuloparib extended progression-free survival, regardless of the addition of apatinib in patients with newly diagnosed advanced ovarian cancer.